CSIMarket
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Stemline Therapeutics Inc's Tangible Leverage Ratio

STML's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




STML Tangible Leverage Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Tangible Equity Change 35.59 % 287.7 % 176.11 % 23.89 % 23.72 %
Y / Y Total Liabilities Change -15.8 % 9.73 % 30.45 % 49.06 % 38.74 %
Tangible Leverage Ratio MRQ 0.16 0.14 0.13 0.27 0.25
Overall Ranking # # # # #
Seq. Tangible Equity Change -9.76 % -6.74 % 74.06 % -7.44 % 158.03 %
Seq. Total Liabilities Change -1.7 % 2.77 % -16.91 % 0.31 % 28.09 %



Tangible Leverage Ratio first quarter 2020 Comment
Despite repayements of liabilities of -1.7%, in I. Quarter ,Tangible Leverage Ratio detoriated to 0.16, below company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the first quarter 2020, 54 other companies have achieved lower Tangible Leverage Ratio than Stemline Therapeutics Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is STML Market Share?
Tangible Leverage Ratio first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 55
Healthcare Sector # 111
Overall Market # 229


Tangible Leverage Ratio Statistics
High Average Low
0.5 0.16 0.03
(Dec 31 2018)   (Sep 30 2013)




Financial Statements
Stemline Therapeutics Inc's Tangible Equity $ 148 Millions Visit STML's Balance sheet
Stemline Therapeutics Inc's Total Liabilities $ 23 Millions Visit STML's Balance sheet
Source of STML's Sales Visit STML's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingMar 31 2020, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioMar 31 2020 MRQ Total LiabilitiesMar 31 2020 MRQ Tangible Equity
Sunesis Pharmaceuticals Inc   0.43 $ 9.401  Millions$ 22.086  Millions
Tetraphase Pharmaceuticals Inc  0.42 $ 9.898  Millions$ 23.295  Millions
Rezolute Inc   0.42 $ 4.375  Millions$ 10.302  Millions
Global Blood Therapeutics Inc   0.42 $ 217.574  Millions$ 523.572  Millions
Intec Pharma Ltd   0.41 $ 5.769  Millions$ 14.220  Millions
Spectrum Pharmaceuticals Inc  0.40 $ 62.224  Millions$ 153.768  Millions
Ardelyx Inc   0.40 $ 67.565  Millions$ 167.757  Millions
Arbutus Biopharma Corp  0.40 $ 29.358  Millions$ 73.256  Millions
Phasebio Pharmaceuticals Inc  0.37 $ 20.043  Millions$ 53.486  Millions
United Therapeutics Corporation  0.37 $ 1,045.400  Millions$ 2,790.200  Millions
Savara Inc   0.37 $ 32.659  Millions$ 87.316  Millions
Bridgebio Pharma Inc   0.36 $ 163.180  Millions$ 449.018  Millions
Siga Technologies Inc  0.35 $ 30.432  Millions$ 87.244  Millions
Fulcrum Therapeutics Inc   0.34 $ 24.225  Millions$ 70.631  Millions
Epizyme Inc   0.34 $ 108.141  Millions$ 315.615  Millions
Rocket Pharmaceuticals Inc   0.34 $ 86.700  Millions$ 255.236  Millions
Blueprint Medicines Corporation  0.34 $ 230.692  Millions$ 682.931  Millions
Arvinas Inc   0.33 $ 70.743  Millions$ 211.707  Millions
Trevena Inc  0.33 $ 9.613  Millions$ 28.795  Millions
Ritter Pharmaceuticals Inc  0.32 $ 1.602  Millions$ 5.015  Millions
Acer Therapeutics Inc   0.32 $ 2.051  Millions$ 6.442  Millions
Kadmon Holdings Inc   0.32 $ 43.011  Millions$ 135.186  Millions
Advaxis Inc   0.31 $ 9.773  Millions$ 31.288  Millions
Heron Therapeutics Inc   0.31 $ 113.473  Millions$ 365.468  Millions
Hepion Pharmaceuticals Inc   0.31 $ 4.229  Millions$ 13.707  Millions
Mei Pharma Inc   0.30 $ 22.125  Millions$ 74.263  Millions
Amarin Corp Plcuk  0.29 $ 164.873  Millions$ 570.878  Millions
Anchiano Therapeutics Ltd   0.28 $ 3.283  Millions$ 11.560  Millions
Agios Pharmaceuticals Inc   0.28 $ 174.439  Millions$ 625.299  Millions
Cormedix Inc   0.27 $ 5.806  Millions$ 21.593  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AMWD's Profile

Stock Price

AMWD's Financials

Business Description

Fundamentals

Charts & Quotes

AMWD's News

Suppliers

AMWD's Competitors

Customers & Markets

Economic Indicators

AMWD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071